Abstract
Whether brain natriuretic peptide (BNP), combined with a cardiopulmonary exercise test (CPx) parameters or echocardiography improves prognostic stratification in mild-to-moderate systolic heart failure (HF) is currently unclear. In 156 consecutive stable outpatients with mild to moderate HF and left ventricular ejection fraction (LVEF) <40%, we assessed the impact of BNP assay, Doppler echocardiography and CPx on survival. Median BNP plasma levels were 207 [90–520] pg/mL. Mean LVEF was 33 ± 7%. Left bundle branch block (LBBB) was present in 52 patients (33%) and a restrictive filling pattern in 35 (22%). The slope of the relation between minute ventilation and carbon dioxide production (VE/VCO2 slope) averaged 35 ± 8; an enhanced ventilatory response (EVR) to exercise (VE/VCO2 slope >35) was found in 67 patients (43%). During 759 ± 346 days of follow-up, 24 patients died. By multivariate analysis, the strongest independent predictors of all-cause death among clinical, echocardiographic variables and BNP were LBBB and beta-blocker treatment. When CPx variables were added, the best predictors of mortality were LBBB, beta-blockade and VE/VCO2 slope. This study highlights the value of a sequential approach, based on clinical, laboratory and functional data to identify high-risk HF patients. BNP assay might constitute a simple alternative tool for patients with an inability or with clinical contraindications to exercise, advanced physical deconditioning and unreliable CPx results. However, whenever feasible, CPx with assessment of EVR is recommended for a more accurate prediction of prognosis.
Similar content being viewed by others
References
Working Group on Cardiac Rehabilitation Exercise Physiology Working Group on Heart Failure of European Society of Cardiology (2001) Recommendations for exercise testing in chronic heart failure patients. Eur Heart J 22:37–45
Arena R, Myers J, Abella J et al (2007) Development of a ventilatory classification system in patients with heart failure. Circulation 115:2410–2417
Remme WJ, Swedberg K (2001) Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22:1527–1560
Opasich C, Pinna GD, Bobbio M et al (1998) Peak exercise oxygen consumption in chronic heart failure: toward efficient use in the individual patient. J Am Coll Cardiol 3:766–775
Kao W, Winkel EM, Johnson MR et al (1997) Role of maximal oxygen consumption in establishment of heart transplant candidacy for heart failure patients with intermediate exercise tolerance. Am J Cardiol 79:1124–1127
Corra U, Mezzani A, Bosimini E et al (2002) Ventilatory response to exercise improves risk stratification in patients with chronic heart failure and intermediate functional capacity. Am Heart J 143:418–426
Ponikowski P, Francis DP, Piepoli MF et al (2001) Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance. Marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 103:967–972
Arena R, Myers J, Hsu L et al (2007) The minute ventilation/carbon dioxide production slope is prognostically superior to the oxygen uptake efficiency slope. J Card Fail 13:462–469
Thohan V (2004) Prognostic implications of echocardiography in advanced heart failure. Curr Opin Cardiol 19:230–249
Bruch C, Gotzmann M, Stypmann J et al (2005) Electrocardiography and Doppler echocardiography for risk stratification in patients with chronic heart failure. Incremental prognostic value of QRS duration and a restrictive mitral filling pattern. J Am Coll Cardiol 45:1072–1075
Whalley GA, Gamble GD, Dini FL et al (2007) Individual patient meta-analyses of restrictive diastolic filling pattern and mortality in patients post acute myocardial infarction and in patients with chronic heart failure. Int J Cardiol 122:207–215
Silver MA, Maisel A, Yancy CW et al (2004) BNP Consensus panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail 10:S1–S30
Cabanes L, Richaud-Thiriez B, Fulla YS et al (2001) Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea. Chest 120:2047–2050
Maisel AS, Krishnaswamy P, Nowak RM et al (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161–167
Isnard R, Pousset F, Chafirovskaia O et al (2003) Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure. Am Heart J 146:729–735
de Groote P, Dagorn JI, Soudan B et al (2004) B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol 43:1584–1589
Pascual-Figal DA, Penafiel P, de la Morena G et al (2007) Relation of B-type natriuretic peptide levels before and after exercise and functional capacity in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 99:1279–1283
Wasserman K, Hansen JE, Sue DY et al (1986) Principles of exercise testing and interpretation. Lea & Febiger, Philadelphia, pp 73–75
Cohen-Solal A, Zannad F, Kayanakis JG et al (1991) Multicentre study of the determination of peak oxygen uptake and ventilatory threshold during bicycle in chronic heart failure. Eur Heart J 12:1055–1063
Mezzani A, Corra U, Bosimini E et al (2003) Contribution of peak respiratory exchange ratio to peak VO2 prognostic reliability in patients with chronic heart failure and severely reduced exercise capacity. Am Heart J 145:1102–1107
Schiller NB, Shah PM, Crawford M et al (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 2:358–367
Baldasseroni S, Opasich C, Gorini M et al (2002) Left bundle branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 143:398–405
Tabrizi F, Englund A, Rosenqvist M et al (2007) Influence of left bundle branch block on long-term mortality in a population with heart failure. Eur Heart J 28:2449–2455
Duncan AM, Darrel PF, Derek GG et al (2004) Limitation of exercise tolerance in chronic heart failure: distinct effects of left bundle—branch block and coronary artery disease. J Am Coll Cardiol 43:1524–1531
Maisel AS, Koon J, Krishnaswamy P et al (2001) Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 141:367–374
Corrà U, Mezzani A, Bosimini E et al (2004) Limited predictive value of cardiopulomonary exercise indices in patients with moderate chronic heart failure treated with carvedilol. Am Heart J 147:553–560
Cicoira M, Davos CH, Florea V et al (2001) Chronic heart failure in the very elderly: clinical status, survival, and prognostic factors in 188 patients more than 70 years old. Am Heart J 142:174–180
Davies LC, Francis DP, Piepoli M et al (2000) Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification. Heart 83:147–151
Mejhert M, Linder-Klingsell E, Edner M et al (2002) Ventilatory variables are strong prognostic markers in elderly patients with heart failure. Heart 88:239–243
Scardovi AB (2004) Clinical applications of brain natriuretic peptide testing. Ital Heart J 5:343–356
Cheng V, Kazanagra R, Garcia A et al (2001) A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 37:386–391
Kruger S, Graf J, Kunz D et al (2002) Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 40:718–722
Scardovi AB, Coletta C, Aspromonte N et al (2007) Brain natriuretic peptide plasma level is a reliable indicator of advanced diastolic dysfunction in patients with chronic heart failure. Eur J Echocardiogr 8:30–36
Troughton RW, Prior DL, Pereira JJ et al (2004) Plasma B-type natriuretic peptide levels in systolic heart failure. J Am Coll Cardiol 43:416–422
Kleber FX, Vietzke G, Wernecke KD et al (2000) Impairment of ventilatory efficiency in heart failure. Prognostic impact. Circulation 101:2803–2809
Arena R, Myers J, Aslam SS et al (2004) Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison. Am Heart J 147:354–360
Piepoli M, Clark AL, Volterrani M et al (1996) Contribution of muscle afferents to the hemodynamic, autonomic and ventilatory responses to exercise in patients with chronic heart failure. Circulation 93:940–952
Narkiewicz K, Pesek CA, van de Borne PJ et al (1999) Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 100:262–267
Ponikowski P, Chua TP, Piepoli M et al (1997) Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 96:2586–2594
Metra M, Dei Cas L, Panina G et al (1992) Exercise hyperventilation chronic congestive heart failure and its relation to functional capacity and hemodynamics. Am J Cardiol 70:622–628
Reindl I, Wernecke KD, Opitz C et al (1998) Impaired ventilatory efficiency in chronic heart failure: possible role of pulmonary vasoconstriction. Am Heart J 136:778–85
Hansen A, Haass M, Zugck C et al (2001) Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure. J Am Coll Cardiol 37:1049–1055
Haug C, Metzele A, Steffgen J et al (1994) Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure. J Clin Invest 72:430–434
Bettencourt P (2004) NT-pro BNP and BNP: biomarkers for heart failure management. Eur J Heart Fail 6:359–363
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scardovi, A.B., De Maria, R., Celestini, A. et al. Prognostic value of brain natriuretic peptide and enhanced ventilatory response to exercise in patients with chronic heart failure. Intern Emerg Med 3, 331–337 (2008). https://doi.org/10.1007/s11739-008-0163-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-008-0163-x